Oncodesign's Unattributed Round

Oncodesign raised a round of funding on August 07, 2009. Investors include OSEO.

Oncodesign (EPA: ALONC) is a biotechnology company and CRO that is able to predict and identify, at a very early stage, each molecule's therapeutic usefulness and potential to become an effective drug…

Articles about Oncodesign's Unattributed Round: